NCT02661438View on ClinicalTrials.gov

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

NACompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

January 12, 2016

Primary Completion Date

March 17, 2016

Study Completion Date

March 17, 2016

Conditions

BronchiectasisPulmonary Disease, Chronic Obstructive

Interventions

DRUG

Placebo to Ciprofloxacin DPI (BAYQ3939)

Placebo to Ciprofloxacin DPI, 3 doses during test session, 1 additional dose for patients during device training

Trial Locations (2)

11435

Jamaica

32960

Vero Beach

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Bayer

INDUSTRY